The year’s second total lunar eclipse saw Earth’s shadow obscure this weekend’s full moon as the home planet lined up perfectly between the moon and the sun. Watch The Virtual Telescope Project’s ...

On September 7, the moon will turn a coppery red during an 82-minute eclipse, one of the most widely seen celestial shows of the decade. A coppery moon glows above Waterton Lakes National Park in ...

Find expert weather insights and travel advice in this essential guide to the 2027 total solar eclipse in Spain, Egypt and North Africa. On Aug. 2, 2027, a total solar eclipse will cast its shadow ...

This Sunday night (Sept. 7-8), Earth will pass directly between the sun and the full Corn Moon to trigger the year's second and final total lunar eclipse. Spanning more than five hours, the celestial ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

No, the world will not go dark this weekend. Rumors about a lengthy total solar eclipse may have been circulating online, but the so-called "eclipse of the century" isn't for another two years. A ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

The sky's orange and green glows cast a "tie-dye" effect around the moon's outline. In March, observers in Chile were treated to an especially spectacular sight, as the night sky lit up with orange ...

(RTTNews) - Northrop Grumman Corp. (NOC), Thursday announced that it has committed $50 million to Firefly Aerospace to accelerate production of their jointly developed medium class launch vehicle, ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...